Research location
Salford
Greater Manchester, United Kingdom
Advertisement
Research activity in Salford
Greater Manchester, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 27 trials and 31 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Salford
27 linked trials · page 1 of 1Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)NCT05658497 · 2023-10-27 · 1 site observation
RECRUITING
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)NCT06940141 · 2025-08-08 · 1 site observation
COMPLETED
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNCT05936151 · 2023-07-20 · 1 site observation
COMPLETED
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.NCT05763121 · 2023-01-30 · 1 site observation
TERMINATED
A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80NCT05348785 · 2022-04-19 · 1 site observation
COMPLETED
Actiste® Diabetes Management as a Service (ADMS) Clinical InvestigationNCT05284071 · 2022-03-14 · 1 site observation
COMPLETED
Impact on Quality of Life From Multi-modality Lung CancerNCT04540757 · 2020-11-25 · 1 site observation
UNKNOWN
WORKWELL: Testing Work Advice for People With ArthritisNCT03942783 · 2019-03-22 · 1 site observation
COMPLETED
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureNCT03829657 · 2019-02-22 · 1 site observation
TERMINATED
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's DiseaseNCT03318523 · 2018-01-10 · 1 site observation
TERMINATED
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)NCT03222973 · 2017-11-15 · 1 site observation
TERMINATED
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic SclerosisNCT03041025 · 2017-06-05 · 1 site observation
COMPLETED
Activity Monitor Use in COPD Patients Undergoing RehabilitationNCT02895152 · 2016-08-01 · 1 site observation
COMPLETED
An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD PatientsNCT02799784 · 2016-07-14 · 1 site observation
COMPLETED
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's DiseaseNCT02542696 · 2015-08-31 · 1 site observation
COMPLETED
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseNCT02477800 · 2015-08-13 · 1 site observation
TERMINATED
Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to MethotrexateNCT02393378 · 2015-04-08 · 1 site observation
TERMINATED
Plegridy Observational ProgramNCT02230969 · 2014-11-12 · 1 site observation
COMPLETED
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple SclerosisNCT02219932 · 2014-09-01 · 1 site observation
COMPLETED
A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 DiabetesNCT02053272 · 2014-02-01 · 1 site observation
COMPLETED
Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation
COMPLETED
Biogen Multiple Sclerosis Pregnancy Exposure RegistryNCT01911767 · 2013-10-30 · 1 site observation
COMPLETED
Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetNCT01931566 · 2013-08-01 · 1 site observation
TERMINATED
An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in AsthmaNCT01706198 · 2012-11-01 · 2 site observations
COMPLETED
A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)NCT01551758 · 2012-03-13 · 4 site observations
COMPLETED
Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple SclerosisNCT01480076 · 2012-02-01 · 1 site observation
COMPLETED
Safety and Efficacy of Saxagliptin Plus Insulin With or Without MetforminNCT00757588 · 2008-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.